MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611065225 A) filed by Geeta University on May 20, 2026, for A Theranostic Pharmaceutical Composition And A Method For Preparation Thereof.
Inventors include Kushant Antil; Dr. Amit Lather; Dr. Seema Rohilla; and Dr. Sunil Jawla.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention discloses a theranostic pharmaceutical composition and a method for preparation thereof. The composition comprises a therapeutic agent, a diagnostic agent, and a carrier system configured to simultaneously deliver therapy and provide diagnostic feedback. The carrier system includes nanoparticles, liposomes, hydrogels, or polymeric matrices capable of targeted delivery. The diagnostic agent enables real-time monitoring of disease conditions or therapeutic response through detectable signals. The method of preparation involves incorporating the therapeutic agent and diagnostic agent into the carrier system followed by stabilization. The invention enables site-specific drug delivery, reduced systemic toxicity, and real-time monitoring of treatment efficacy. The composition is suitable for applications in cancer therapy, infectious diseases, and personalized medicine, providing a unified and scalable platform that integrates treatment and diagnostics into a single system.
Disclaimer: Curated by HT Syndication.
